Ingenuity Systems and Affymetrix Partner to Eliminate Microarray Expression Analysis Bottleneck

 Ingenuity Systems and Affymetrix Partner to Eliminate Microarray Expression
                             Analysis Bottleneck

PR Newswire

REDWOOD CITY, Calif. and SANTA CLARA, Calif., April 8, 2013

REDWOOD CITY, Calif. and SANTA CLARA, Calif., April 8, 2013 /PRNewswire/ --
Ingenuity® Systems, a leading provider of biomedical information and analysis
solutions, and Affymetrix®, Inc. (NASDAQ: AFFX) today announced that they will
co-promote Ingenuity® iReport™ with Affymetrix expression microarray products
effectively eliminating a bottleneck for researchers working with human, mouse
and rat applications by coupling a fast and accurate statistical analysis and
biological interpretation workflow with the gold-standard platform for gene
expression studies.

Affymetrix expression microarrays are the standard methodology used for many
research and discovery applications and when combined with Ingenuity iReport,
an interactive web-based report that leverages the Ingenuity Knowledge Base of
biological and chemical findings from the peer reviewed literature and
databases, deliver researchers a 'sample to insight' continuous workflow
allowing for rapid, confident interpretation of results without the need for
bioinformatics experience or support.

"We are excited to partner with Ingenuity Systems to provide our array users
with access to the intuitive biological and statistical analysis platform
offered by iReport," said Kevin Cannon, Ph.D., SVP - Expression Business Unit
at Affymetrix. "Bundling together our robust expression microarrays with the
iReport platform will provide Affymetrix' customers with a simple and accurate
tool to convert data into biologically relevant results."

"By leveraging Ingenuity iReport with Affymetrix gene expression arrays for
our study on a mouse model of Familial Hypertrophic Cardiomyopathy, we
accelerated our data interpretation several-fold compared to using other
analysis tools.Their rapid and effectively-blind analysis provided an
unbiased validation of our data. Additionally, iReport allowed us to identify
and explore genes of interest found with Affymetrix gene chips, yet not
identified by other analysis tools," said Adrian Grimes, Ph.D., from the
Department of Pediatrics at the University of Wisconsin.

About Ingenuity® Systems

Ingenuity® Systems is a leading provider of biomedical information and
analysis solutions for the exploration, interpretation and analysis of complex
biological systems in life science research and molecular diagnostics. Today,
Ingenuity's solutions are used by tens of thousands of researchers and
clinicians at hundreds of leading pharmaceutical, biotechnology, academic,
diagnostic and clinical institutions worldwide.

About Affymetrix

Affymetrix' technologies are used by the world's top pharmaceutical,
diagnostic, and biotechnology companies, as well as leading academic,
government, and non-profit research institutes. More than 2,300 microarray
systems have been shipped around the world and more than 48,000 peer-reviewed
papers have been published citing our technologies. Affymetrix is
headquartered in Santa Clara, California, and has manufacturing facilities in
Cleveland, Ohio, San Diego, Vienna and Singapore. The Company has about 1,100
employees worldwide and maintains sales and distribution operations across
Europe, Asia, and Latin America. For more information about Affymetrix, please
visit www.affymetrix.com.

PLEASE NOTE: Affymetrix® and the Affymetrix logo are the property of
Affymetrix, Inc. All other trademarks are the property of their respective
owners.

Products mentioned in this release are for research use only. Not for
diagnostic procedures.

SOURCE Ingenuity Systems

Website: http://www.ingenuity.com
Website: http://www.affymetrix.com
Contact: Dione Bailey, Director of Marketing, Ingenuity Systems,
+1-650-381-5025, dbailey@ingenuity.com
 
Press spacebar to pause and continue. Press esc to stop.